{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:13:48Z","timestamp":1791807228566,"version":"4.3.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"Background<\/jats:title>In 1997 the European Parkinson\u2019s Disease Associations launched the Charter for People with Parkinson\u2019s disease that stated the right of patients to be informed and trained on the disease, its course, and treatments available. To date, few data analyzed the effectiveness of education program on motor and non-motor symptoms of PD.<\/jats:p><\/jats:sec>Objective<\/jats:title>The aim of this study was to evaluate the efficacy of an education program as it was a pharmacological treatment, thus choosing as the primary endpoint the change in daily OFF hours, the most widely used outcome in pharmaceutical clinical trials on PD patients with motor fluctuations. Secondary outcomes were change in motor and non-motor symptoms, quality of life and social functioning. The long-term efficacy of the education therapy was also evaluated by analyzing data collected at 12- and 24-weeks follow-up outpatient visits.<\/jats:p><\/jats:sec>Methods<\/jats:title>One hundred and twenty advanced patients and their caregivers were assigned to the intervention or control group in a single-blind, multicentric, prospective, randomized study evaluating an education program structured in individual and group sessions over a 6-weeks period.<\/jats:p>At the end of study, the intervention group showed a significant reduction in daily OFF hours compared to control patients (\u22121.07\u2009\u00b1\u20090.78 vs. 0.09\u2009\u00b1\u20090.35, p<\/jats:italic>\u2009&lt;\u20090.0001) and a significant improvement was also reported in most secondary outcomes. Patients retained significant medication adherence and daily OFF hours reduction at 12- and 24-weeks follow-up.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>The results obtained demonstrated that education programs may translate in a notable improvement in motor fluctuations and non-motor symptoms in advanced PD patients.<\/jats:p>Clinical Trial Registration:<\/jats:bold>Clinicaltrials.gov<\/jats:ext-link>, identifier NCT04378127.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1167685","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:48:32Z","timestamp":1681796912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Therapeutic education for empowerment and engagement in patients with Parkinson\u2019s disease: A non-pharmacological, interventional, multicentric, randomized controlled trial"],"prefix":"10.3389","volume":"14","author":[{"given":"Maria Francesca","family":"De Pandis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Torti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Rotondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfranco","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Levi Della Vida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Viselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Servodidio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Stocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1532-5415.2004.52219.x","article-title":"Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease","volume":"52","author":"Weintraub","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMS quest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov Disord"},{"key":"ref3","volume-title":"Therapeutic patient education: Continuing education programmes for health care providers in the field of prevention of chronic diseases: Report of a WHO working group","year":"1998"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11910-017-0717-2","article-title":"Integrating patient concerns into Parkinson's disease management","volume":"17","author":"Lim","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref5","volume-title":"Patient Engagement","year":"2016"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.pec.2016.07.026","article-title":"Patient empowerment, patient participation and patient-centeredness in hospital care: a concept analysis based on a literature review","volume":"99","author":"Castro","year":"2016","journal-title":"Patient Educ Couns"},{"key":"ref7","first-page":"2","article-title":"Chronic disease management: what will it take to improve care for chronic illness?","volume":"1","author":"Wagner","year":"1998","journal-title":"Eff Clin Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12913-015-0854-8","article-title":"Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review","volume":"15","author":"Davy","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1468-1331.2011.03532.x","article-title":"Move for change part I: a European survey evaluating the impact of the EPDA charter for people with Parkinson\u2019s disease","volume":"19","author":"Bloem","year":"2012","journal-title":"Eur J Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1468-1331.2012.03876.x","article-title":"Move for change part II: a European survey evaluating the impact of the EPDA charter for people with Parkinson's disease","volume":"20","author":"Stocchi","year":"2013","journal-title":"Eur J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/ene.12544","article-title":"Move for change part III: a European survey evaluating the impact of the EPDA charter for people with Parkinson's disease","volume":"22","author":"Bloem","year":"2015","journal-title":"Eur J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/bmj.g1838","article-title":"Revolutionising management of chronic disease: the ParkinsonNet approach","volume":"348","author":"Bloem","year":"2014","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0002-9343(94)90322-0","article-title":"Patient education and health promotion can be effective in Parkinson's disease: a randomized controlled trial. PROPATH advisory board","volume":"97","author":"Montgomery","year":"1994","journal-title":"Amer J Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.parkreldis.2006.05.003","article-title":"Members of the EduPark consortium. An innovative education programme for people with Parkinson's disease and their carers","volume":"12","author":"Simons","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.parkreldis.2009.07.009","article-title":"The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers","volume":"16","author":"A'Campo","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e0162646","DOI":"10.1371\/journal.pone.0162646","article-title":"Clinical impact and cost-effectiveness of an education program for PD patients: a randomized controlled trial","volume":"11","author":"Canivet","year":"2016","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pec.2006.08.005","article-title":"Patient education in Parkinson's disease: formative evaluation of a standardized programme in seven European countries","volume":"65","author":"Macht","year":"2007","journal-title":"Patient Educ Couns"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/mds.20248","article-title":"Parkinson's disease home diary: further validation and implications for clinical trials","volume":"19","author":"Hauser","year":"2004","journal-title":"Mov Disord"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.21198","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov Disord"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society task force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive validity of a medication adherence measure in an outpatient setting","volume":"10","author":"Morisky","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref23","volume-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref26","volume-title":"The Parkinson\u2019s Disease Questionnaire: User Manual for the PDQ-39, PDQ-8 and PDQ Summary Index","author":"Jenkinson","year":"1998"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4081\/monaldi.2012.121","article-title":"EuroQol-5D (EQ-5D): an instrument for measuring quality of life","volume":"78","author":"Balestroni","year":"2012","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/geront\/29.6.798","article-title":"Application of a multidimensional caregiver burden inventory","volume":"29","author":"Novak","year":"1989","journal-title":"Gerontologist"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/0891988719845509","article-title":"Neurologist strategies for optimizing the Parkinson's disease clinical encounter","volume":"32","author":"Schwartz","year":"2019","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1755-5949.2011.00253.x","article-title":"Patient diaries as a clinical endpoint in Parkinson's disease clinical trials","volume":"18","author":"Papapetropoulos","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0891988719841721","article-title":"Inpatient enhanced multidisciplinary care effects on the quality of life for Parkinson disease: a quasi-randomized controlled trial","volume":"32","author":"Marumoto","year":"2019","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","article-title":"Patient medication adherence: measures in daily practice","volume":"26","author":"Jimmy","year":"2011","journal-title":"Oman Med J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease\u2014an evidence\u2010based medicine review","volume":"34","author":"Seppi","year":"","journal-title":"Mov Disord"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.2147\/NDT.S213917","article-title":"Impact of non-motor symptoms in Parkinson's disease: a PMD Alliance survey","volume":"15","author":"Hermanowicz","year":"2019","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1167685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:48:38Z","timestamp":1681796918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1167685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":36,"alternative-id":["10.3389\/fneur.2023.1167685"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1167685","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"article-number":"1167685"}}